Browsing byAuthorCheung, BB

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 19 of 19
Issue DateTitleAuthor(s)
2021-03-03A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastomaCheung, BB; Kleynhans, A; Mittra, R; Kim, PY; Holien, JK; Nagy, Z; Ciampa, OC; Seneviratne, JA; Mayoh, C; Raipuria, M; Gadde, S; Massudi, H; Wong, IPL; Tan, O; Gong, A; Suryano, A; Diakiw, SM; Liu, B; Arndt, GM; Liu, T; Kumar, N; Sangfelt, O; Zhu, S; Norris, MD; Haber, M; Carter, DR; Parker, MW; Marshall, GM
2016-08-09A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner.Sutton, SK; Carter, DR; Kim, P; Tan, O; Arndt, GM; Zhang, XD; Baell, J; Noll, BD; Wang, S; Kumar, N; McArthur, GA; Cheung, BB; Marshall, GM
2016-08-09A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner.Sutton, SK; Carter, DR; Kim, P; Tan, O; Arndt, GM; Zhang, XD; Baell, J; Noll, BD; Wang, S; Kumar, N; McArthur, GA; Cheung, BB; Marshall, GM
2021-03-25An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stabilityNagy, Z; Seneviratne, JA; Kanikevich, M; Chang, W; Mayoh, C; Venkat, P; Du, Y; Jiang, C; Salib, A; Koach, J; Carter, DR; Mittra, R; Liu, T; Parker, MW; Cheung, BB; Marshall, GM
2020-10Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastoma.Tee, AE; Ciampa, OC; Wong, M; Fletcher, JI; Kamili, A; Chen, J; Ho, N; Sun, Y; Carter, DR; Cheung, BB; Marshall, GM; Liu, PY; Liu, T
2019-11-01Drugging MYCN oncogenic signaling through the MYCN-PA2G4 binding interfaceKoach, J; Holien, JK; Massudi, H; Carter, DR; Ciampa, OC; Herath, M; Lim, T; Seneviratne, JA; Milazzo, G; Murray, JE; McCarroll, JA; Liu, B; Mayoh, C; Keenan, B; Stevenson, BW; Gorman, MA; Bell, JL; Doughty, L; Hüttelmaier, S; Oberthuer, A; Fischer, M; Gifford, AJ; Liu, T; Zhang, X; Zhu, S; Gustafson, WC; Haber, M; Norris, MD; Fletcher, JI; Perini, G; Parker, MW; Cheung, BB; Marshall, GM
2016-06Glutathione biosynthesis is upregulated at the initiation of MYCN-driven neuroblastoma tumorigenesis.Carter, DR; Sutton, SK; Pajic, M; Murray, J; Sekyere, EO; Fletcher, J; Beckers, A; De Preter, K; Speleman, F; George, RE; Haber, M; Norris, MD; Cheung, BB; Marshall, GM
2019-09-04Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasisSutton, SK; Cheung, BB; Massudi, H; Tan, O; Koach, J; Mayoh, C; Carter, DR; Marshall, GM
2019-01-01Increase in DNA damage by MYCN knockdown through regulating nucleosome organization and chromatin state in neuroblastomaHu, X; Zheng, W; Zhu, Q; Gu, L; Du, Y; Han, Z; Zhang, X; Carter, DR; Cheung, BB; Qiu, A; Jiang, C
2019-01-30Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastomaGamble, LD; Purgato, S; Murray, J; Xiao, L; Yu, DMT; Hanssen, KM; Giorgi, FM; Carter, DR; Gifford, AJ; Valli, E; Milazzo, G; Kamili, A; Mayoh, C; Liu, B; Eden, G; Sarraf, S; Allan, S; Giacomo, SD; Flemming, CL; Russell, AJ; Cheung, BB; Oberthuer, A; London, WB; Fischer, M; Trahair, TN; Fletcher, JI; Marshall, GM; Ziegler, DS; Hogarty, MD; Burns, MR; Perini, G; Norris, MD; Haber, M
2016-01-01The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expressionTee, AE; Liu, B; Song, R; Li, J; Pasquier, E; Cheung, BB; Jiang, C; Marshall, GM; Haber, M; Norris, MD; Fletcher, JI; Dinger, ME; Liu, T
2021-09-24MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation.De Wyn, J; Zimmerman, MW; Weichert-Leahey, N; Nunes, C; Cheung, BB; Abraham, BJ; Beckers, A; Volders, P-J; Decaesteker, B; Carter, DR; Look, AT; De Preter, K; Van Loocke, W; Marshall, GM; Durbin, AD; Speleman, F; Durinck, K
2016-10-11MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma.Fabian, J; Opitz, D; Althoff, K; Lodrini, M; Hero, B; Volland, R; Beckers, A; de Preter, K; Decock, A; Patil, N; Abba, M; Kopp-Schneider, A; Astrahantseff, K; Wünschel, J; Pfeil, S; Ercu, M; Künkele, A; Hu, J; Thole, T; Schweizer, L; Mechtersheimer, G; Carter, D; Cheung, BB; Popanda, O; von Deimling, A; Koster, J; Versteeg, R; Schwab, M; Marshall, GM; Speleman, F; Erb, U; Zoeller, M; Allgayer, H; Simon, T; Fischer, M; Kulozik, AE; Eggert, A; Witt, O; Schulte, JH; Deubzer, HE
2016-10-11MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma.Fabian, J; Opitz, D; Althoff, K; Lodrini, M; Hero, B; Volland, R; Beckers, A; de Preter, K; Decock, A; Patil, N; Abba, M; Kopp-Schneider, A; Astrahantseff, K; Wünschel, J; Pfeil, S; Ercu, M; Künkele, A; Hu, J; Thole, T; Schweizer, L; Mechtersheimer, G; Carter, D; Cheung, BB; Popanda, O; von Deimling, A; Koster, J; Versteeg, R; Schwab, M; Marshall, GM; Speleman, F; Erb, U; Zoeller, M; Allgayer, H; Simon, T; Fischer, M; Kulozik, AE; Eggert, A; Witt, O; Schulte, JH; Deubzer, HE
2018-06-15Network modeling of microRNA-mRNA interactions in neuroblastoma tumorigenesis identifies miR-204 as a direct inhibitor of MYCNOoi, CY; Carter, DR; Liu, B; Mayoh, C; Beckers, A; Lalwani, A; Nagy, Z; De Brouwer, S; Decaesteker, B; Hung, TT; Norris, MD; Haber, M; Liu, T; De Preter, K; Speleman, F; Cheung, BB; Marshall, GM
2021-07-06Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemiaVan Thillo, Q; De Bie, J; Seneviratne, JA; Demeyer, S; Omari, S; Balachandran, A; Zhai, V; Tam, WL; Sweron, B; Geerdens, E; Gielen, O; Provost, S; Segers, H; Boeckx, N; Marshall, GM; Cheung, BB; Isobe, K; Kato, I; Takita, J; Amos, TG; Deveson, IW; McCalmont, H; Lock, RB; Oxley, EP; Garwood, MM; Dickins, RA; Uyttebroeck, A; Carter, DR; Cools, J; de Bock, CE
2021-03Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy.Chen, J; Nelson, C; Wong, M; Tee, AE; Liu, PY; La, T; Fletcher, JI; Kamili, A; Mayoh, C; Bartenhagen, C; Trahair, TN; Xu, N; Jayatilleke, N; Wong, M; Peng, H; Atmadibrata, B; Cheung, BB; Lan, Q; Bryan, TM; Mestdagh, P; Vandesompele, J; Combaret, V; Boeva, V; Wang, JY; Janoueix-Lerosey, I; Cowley, MJ; MacKenzie, KL; Dolnikov, A; Li, J; Polly, P; Marshall, GM; Reddel, RR; Norris, MD; Haber, M; Fischer, M; Zhang, XD; Pickett, HA; Liu, T
2019-11-05The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35.Liu, PY; Tee, AE; Milazzo, G; Hannan, KM; Maag, J; Mondal, S; Atmadibrata, B; Bartonicek, N; Peng, H; Ho, N; Mayoh, C; Ciaccio, R; Sun, Y; Henderson, MJ; Gao, J; Everaert, C; Hulme, AJ; Wong, M; Lan, Q; Cheung, BB; Shi, L; Wang, JY; Simon, T; Fischer, M; Zhang, XD; Marshall, GM; Norris, MD; Haber, M; Vandesompele, J; Li, J; Mestdagh, P; Hannan, RD; Dinger, ME; Perini, G; Liu, T
2020-11-12Withaferin A activates TRIM16 for its anti-cancer activity in melanoma.Nagy, Z; Cheung, BB; Tsang, W; Tan, O; Herath, M; Ciampa, OC; Shadma, F; Carter, DR; Marshall, GM